Society for Research on Nicotine and Tobacco (SRNT) 2015 Annual Meeting

The Society for Research on Nicotine and Tobacco (SRNT) is the leading association focused on this special area of research. SRNT was founded in 1994 to coordinate and advance research on a broad array of topics ranging from the pharmacology of nicotine to the societal influences on use of tobacco.  The Society has flourished in the years since its inception and now has over 1100 members, in more than 40 countries around the world.

Schedule

25 February

7:00 to 7:10

C Haziza

Reduced exposure to harmful and potentially harmful constituents after five days of use of a candidate modified risk tobacco product (the tobacco heating system 2.2): a comparison with continued combustible cigarette use or smoking abstinence. - POS5-5

25 February

7:10 to 7:20

C Haziza

Pharmacokinetics of nicotine and subjective effects following the single use of a non-menthol and menthol version of tobacco heating system2.2 In Two Studies in Japan: a comparison with single use of a combustible cigarette and nicotine gum. - POS5-4

25 February

7:20 to 7:30

C Haziza

Pharmacokinetics of nicotine and subjective effects following the single use of a menthol version of a tobacco heating system2.2 in the US: a comparison with single use of a combustible cigarette and nicotine nasal spray. - POS5-35

25 February

7:30 to 7:40

C Chrea

Psychometric validation of the PRI (Perceived Risk Instrument), a scale to measure perceived risks associated with the use of tobacco-related products. - POS4-139

25 February

7:40 to 7:50

Z Sponsiello Wang

Population health impact model to estimate the effect of introducing modified risk tobacco products on mortality - POS3-130

25 February

7:50 to 8:00

F Martin

Application of Systems Pharmacology to Identify Exposure Response Markers in Peripheral Blood After Switching to a Candidate Modified Risk Tobacco Product: the Tobacco Heating System 2.1 (THS 2.1) - POS2-7

25 February

8:00 to 8:10

C Mathis

Human 3D organotypic nasal epithelial tissue culture as an in vitro model to evaluate effects of cigarette smoke and a candidate Modified Risk Tobacco Product: the Tobacco Heating System 2.2 - POS2-48

25 February

8:10 to 8:20

M Esposito

Toxicological evaluation of inhaled Nicotine and Pyruvic acid Aerosols (separately and combined) in Sprague-Dawley Rats in a 28-day OECD 412 Inhalation Study - POS2-22

25 February

8:30 to 8:40

A Kuczaj

Modeling transport and evolution of aerosols for accurate predictions of local deposition in an in-vitro exposure system - POS2-53

25 February

8:40 to 8:50

E Veljkovic

The impact of switching to pMRTP on the development of cigarette smoke-induced COPD in C57BL/6 mice - POS2-34

25 February

8:50 to 9:00

N Chaudhary

Molecular markers of early stage COPD in plasma, sputum, and nasal epithelium from a case controlled study. - POS1-4

25 February

9:00 to 9:10

S Maeder

C Goujon-Ginglinger

Indoor Air Chemistry (IAC) - Comparative Study Between Conventional Cigarette And Heat-Not-Burn Technology - POS5-42

Coming soon

25 February

9:10 to 9:20

G de La Bourdonnaye

Investigation on puffing topography parameters and product evaluation recorded during five days of use of the Tobacco Heating System 2.2: A comparison with continued combustible cigarette use - POS5-6